Stay updated on Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Sign up to get notified when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer has been updated to reflect a newer ClinicalTrials.gov release revision (v3.5.3 instead of v3.5.2), indicating a version change for the site display rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-25T05:29:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:48:38.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T07:01:07.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:23:24.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:39:46.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page shows an addition of Revision: v3.4.1 and a deletion of Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:58:35.000Z thumbnail image

Stay in the know with updates to Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.